Shopping Cart
- Remove All
- Your shopping cart is currently empty
Firuglipel is an orally available and selective agonist of GPR119.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.729 € | 8-10 weeks | |
50 mg | 2.261 € | 8-10 weeks | |
100 mg | 2.945 € | 8-10 weeks |
Description | Firuglipel is an orally available and selective agonist of GPR119. |
In vitro | Firuglipel increases intracellular cAMP in a concentration-dependent manner in rat, human, and mouse GPR119-expressing Chinese hamster ovary (CHO)-K1 cells (EC50: 51.5, 98.4, and 108.1 nM, respectively). Firuglipel has no effect on intracellular cAMP in pcDNA3.1/CHO-K1 cells. |
In vivo | Firuglipel (1-30 mg/kg) upregulates glucagon-like peptide-1. It also enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats. |
Molecular Weight | 467.49 |
Formula | C25H26FN3O5 |
Cas No. | 1371591-51-3 |
Relative Density. | 1.31g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.